TP53 and cancer: Indeed, Nutlin-3a treatment inhibited thegrowth of multiple p53 wild-type human tumor cell lines grown as xenografts innude mice [16,17], and Nutlin-3a causes a pronounced cell cycle arrest orapoptotic response in p53 wild-type cancer cell lines [17,18].